Psychedelic Preparation & Integration
Psychedelic experiences can be powerful, but the experience itself is only part of the process. What you do before and after matters just as much. Preparation and integration therapy provide the structure to approach a psychedelic experience intentionally and to make lasting use of what comes up.
I work with clients who are planning experiences with ketamine, psilocybin, MDMA, ayahuasca, and other substances. I also work with people who have already had an experience and want help processing it, whether it happened recently or years ago.
What This Includes
Preparation
…is the work that happens before a psychedelic experience. This includes exploring your intentions, identifying fears or expectations, building psychological readiness, and thinking through practical considerations like set and setting.
Integration
…is the work that happens after. Psychedelic experiences can bring up difficult emotions, old memories, shifts in perspective, and new insights. Integration provides a space to process that material, examine what came up, and figure out how to apply it to your daily life.
What This Does Not Include
I do not administer, facilitate, or supervise dosing sessions of any psychedelic substance. I do not provide medical screening, prescribing, or medical clearance. I do not provide referrals to underground or illegal psychedelic providers. I do not provide guidance on sourcing, dosing, or self-administration of controlled substances.
My role is the psychological work before and after psychedelic experiences that occur elsewhere, under the care of another provider.
Training and Background
My work in psychedelic therapy draws from multiple levels of training and experience. I completed the Ketamine Research Foundation Residential Programme in Barcelona (Levels 1 and 2), which focuses on the clinical and phenomenological dimensions of ketamine assisted psychotherapy. I also completed the Polaris Insight Center Ketamine Assisted Psychotherapy Workshop (Modules 1 through 5), covering clinical protocols, safety, and therapeutic technique during dosing sessions. I am currently completing the Fluence Psychedelic Therapy Certificate Program.
Before becoming a clinician, I worked in clinical trials where I administered Spravato (intranasal esketamine) and coordinated with medical teams on adverse event monitoring and research protocols. That experience gave me a practical understanding of what happens during ketamine administration, which informs the preparation and integration work I do now.
I presented research on psychedelic-assisted psychotherapy at Psychedelic Science 2025 in Denver, and my dissertation was on Psychedelic-Assisted Psychotherapy as well.
